GENERIC NAME:
Abiraterone Acetate Film-Coated Tablets
INDICATIONS:
Treatment of prostate cancer in adult men that
has spread to other parts of the body (metastatic), in combination with
prednisone or prednisolone
Early-stage hormone-sensitive disease, in
combination with androgen deprivation therapy (ADT), together with prednisone
or prednisolone
STRENGTH:
250 mg abiraterone acetate per film-coated
tablet
PACK SIZE:
HDPE bottle with child-resistant polypropylene
closure containing 120 film-coated tablets
DOSAGE FORM:
Film-coated tablets for oral use
CATEGORIES:
Pharmaceuticals
THERAPEUTIC CLASS:
Androgen Biosynthesis (CYP17) Inhibitor –
Hormone Antagonist (ATC: L02BX03)
At Amgomed, we recognize that robust business relationships are pivotal in delivering superior healthcare solutions. As an established entity in the pharmaceutical industry, we have cultivated enduring partnerships with global manufacturers to introduce innovative oncology products to patients across Pakistan.
